Literature DB >> 18445388

Food-borne viruses in Europe network report: the norovirus GII.4 2006b (for US named Minerva-like, for Japan Kobe034-like, for UK V6) variant now dominant in early seasonal surveillance.

J Siebenga1, Annelies Kroneman, H Vennema, E Duizer, M Koopmans.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18445388

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


× No keyword cloud information.
  24 in total

1.  Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Authors:  Kari Debbink; Lisa C Lindesmith; Eric F Donaldson; Veronica Costantini; Martina Beltramello; Davide Corti; Jesica Swanstrom; Antonio Lanzavecchia; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

2.  Molecular changes associated with altered patterns of norovirus outbreak epidemics in Victoria, Australia, in 2006 to 2007.

Authors:  Leesa D Bruggink; John A Marshall
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

3.  The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency.

Authors:  Jeremy M Woodward; Effrossyni Gkrania-Klotsas; Anthony Yk Cordero-Ng; Aloysious Aravinthan; Betty N Bandoh; Hongxiang Liu; Susan Davies; Hongyi Zhang; Philip Stevenson; Martin D Curran; Dinakantha Kumararatne
Journal:  Am J Gastroenterol       Date:  2015-01-27       Impact factor: 10.864

Review 4.  Norwalk virus-like particles as vaccines.

Authors:  Melissa Herbst-Kralovetz; Hugh S Mason; Qiang Chen
Journal:  Expert Rev Vaccines       Date:  2010-03       Impact factor: 5.217

5.  Molecular characterization of noroviruses and rotaviruses involved in a large outbreak of gastroenteritis in Northern Italy.

Authors:  Ilaria Di Bartolo; Marina Monini; Marina Nadia Losio; Enrico Pavoni; Antonio Lavazza; Franco Maria Ruggeri
Journal:  Appl Environ Microbiol       Date:  2011-06-10       Impact factor: 4.792

6.  Characterization of norovirus-associated traveler's diarrhea.

Authors:  N Ajami; H Koo; C Darkoh; R L Atmar; P C Okhuysen; Z-D Jiang; J Flores; H L Dupont
Journal:  Clin Infect Dis       Date:  2010-07-15       Impact factor: 9.079

7.  Norovirus GII.4 strain antigenic variation.

Authors:  Lisa C Lindesmith; Eric F Donaldson; Ralph S Baric
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

8.  Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants.

Authors:  J Joukje Siebenga; Philippe Lemey; Sergei L Kosakovsky Pond; Andrew Rambaut; Harry Vennema; Marion Koopmans
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

9.  Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study.

Authors:  Ming Tan; Ming Xia; Sheng Cao; Pengwei Huang; Tibor Farkas; Jarek Meller; Rashmi S Hegde; Xuemei Li; Zihe Rao; Xi Jiang
Journal:  Virology       Date:  2008-08-08       Impact factor: 3.616

10.  Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.

Authors:  Lisa C Lindesmith; Eric F Donaldson; Martina Beltramello; Stefania Pintus; Davide Corti; Jesica Swanstrom; Kari Debbink; Taylor A Jones; Antonio Lanzavecchia; Ralph S Baric
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.